We are live on
!
Find out more
ADIM
Alpha DNA Investment Management Portfolio holdings
AUM
$8.98M
1-Year Est. Return
26.05%
This Fund
S&P 500
This Quarter
Est. Return
-4.55%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.64M
AUM Growth
-$255M
(-97%)
Cap. Flow
-$254M
Cap. Flow
% of AUM
-3,329.77%
Top 10 Holdings %
Top 10 Hldgs %
97.95%
Holding
189
New
–
Increased
–
Reduced
9
Closed
178
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$5.28M |
| 2 |
Morgan Stanley
MS
|
+$5.02M |
| 3 |
JPMorgan Chase
JPM
|
+$4.84M |
| 4 |
Apple
AAPL
|
+$4.78M |
| 5 |
Accenture
ACN
|
+$4.75M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.99% |
| 2 | Financials | 12.56% |
| 3 | Communication Services | 7.8% |
| 4 | Industrials | 6.24% |
| 5 | Healthcare | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Moody's
MCO
$82.5B
| – | – |
-741
| Closed | -$351K |
|
102
MongoDB
MDB
$35.3B
| – | – |
-3,343
| Closed | -$778K |
|
103
Mondelez International
MDLZ
$78.9B
| – | – |
-29,243
| Closed | -$1.75M |
|
104
Medtronic
MDT
$116B
| – | – |
-22,168
| Closed | -$1.77M |
|
105
Mirum Pharmaceuticals
MIRM
$5.99B
| – | – |
-10,663
| Closed | -$441K |
|
106
MKS Inc
MKSI
$19.9B
| – | – |
-4,163
| Closed | -$435K |
|
107
Marathon Petroleum
MPC
$94.5B
| – | – |
-3,010
| Closed | -$420K |
|
108
Merck
MRK
$322B
| – | – |
-11,222
| Closed | -$1.12M |
|
109
Marvell Technology
MRVL
$191B
| – | – |
-7,917
| Closed | -$874K |
|
|
110
Morgan Stanley
MS
$338B
| – | – |
-39,921
| Closed | -$5.02M |
|
111
Meritage Homes
MTH
$4.81B
| – | – |
-6,438
| Closed | -$495K |
|
112
MACOM Technology Solutions
MTSI
$22.9B
| – | – |
-3,253
| Closed | -$423K |
|
113
NextEra Energy
NEE
$179B
| – | – |
-25,782
| Closed | -$1.85M |
|
114
Nicolet Bankshares
NIC
$3.72B
| – | – |
-4,056
| Closed | -$426K |
|
115
Northern Trust
NTRS
$34.4B
| – | – |
-7,227
| Closed | -$741K |
|
116
NVIDIA
NVDA
$5.27T
| – | – |
-14,306
| Closed | -$1.92M |
|
117
Blue Owl Capital
OBDC
$5.76B
| – | – |
-29,903
| Closed | -$452K |
|
118
Owens Corning
OC
$12.6B
| – | – |
-4,580
| Closed | -$780K |
|
119
Omega Healthcare
OHI
$13.8B
| – | – |
-11,991
| Closed | -$454K |
|
120
Okta
OKTA
$26.1B
| – | – |
-5,898
| Closed | -$465K |
|
121
Omnicell
OMCL
$1.68B
| – | – |
-9,626
| Closed | -$429K |
|
122
Oshkosh
OSK
$9.62B
| – | – |
-4,187
| Closed | -$398K |
|
123
Bank OZK
OZK
$5.66B
| – | – |
-13,195
| Closed | -$588K |
|
124
Palo Alto Networks
PANW
$313B
| – | – |
-6,205
| Closed | -$1.13M |
|
125
PACCAR
PCAR
$69.8B
| – | – |
-7,267
| Closed | -$756K |
|
Similar funds
CAWM
AI
PC
CP
AVM
CSD
NP
BPWM
Alpha DNA Investment Management's Q1 2025 Portfolio in Review
As of Q1 2025, Alpha DNA Investment Management held 189 positions worth $7.64M, down 97% from $263M the previous quarter. Its ten largest holdings account for 98% of the portfolio.
Alpha DNA Investment Management withdrew a net $254M in Q1 2025, closing 178 positions and reducing 9 holdings. Its most notable exit was Wells Fargo, an estimated $5.28M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 21% a quarter earlier, followed by Financials and Communication Services.
- Alpha DNA Investment Management's biggest Q1 2025 reduction was JPMorgan Chase, cutting an estimated $4.84M.
- Alpha DNA Investment Management fully exited Wells Fargo in Q1 2025, selling an estimated $5.28M.
- Alpha DNA Investment Management's ten largest holdings make up 98% of its $7.64M portfolio in Q1 2025.
- Alpha DNA Investment Management opened 0 new positions and closed 178 in Q1 2025.
- Alpha DNA Investment Management's portfolio value fell 97% quarter-over-quarter to $7.64M.
Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.